Natural products and the life cycle of Toxoplasma gondii
DOI:
https://doi.org/10.5281/zenodo.19894928Palavras-chave:
Toxoplasma gondii, life cycle, natural products, biotechnological potential, health educationResumo
The World Health Organization recognizes Toxoplasmosis as a major foodborne disease worldwide prevalence. The illness is a zoonosis occurring in areas of greater social vulnerability due to a lack of knowledge about the life cycle of the agent, the protozoan Toxoplasma gondii, when it contaminates soil, water, and consequently, food. The present study revision summarized evidence on natural compounds with anti-T. gondii activity, identified gaps, and proposed priorities for research in plant biotechnology, as several plant assays were communicated around the world, reinforcing the activity upon its life cycle. The authors sought to present the importance of Toxoplasmosis from a broad perspective, addressing aspects such as the impact upon host immunity, and the significance of refined studies evaluating natural products that may assist in controlling, or at least reducing, the harmful effects of this important parasitic infection. Besides the plant biotechnological research potential upon life cycle of Toxoplasma gondii. Finally, it was presented a booklet to health promotion through health education.
Referências
ABBAS, A.; ZHENG, C.; PANNERDEN, C.; NEWSHOLME, W.; HILTON, R. (2020). Primary toxoplasmosis complicated by possible IRIS 15 years after renal transplantation, 100021. https://doi.org/10.1016/j.clinpr.2020.100021
ABUBACKER, M.N.; DEEPALAKSHMI, T. In vitro antifungal potentials of bioactive compound methyl ester of hexadecanoic acid isolated from Annona muricata Linn. (Annonaceae) leaves. Biosci Biotechnol Res Asia, 10 (2013), pp. 879-884, 10.13005/bbra/1211
ADEKUNLE, R.; SHERMAN, A.; SPICER, J.; MESSINA, J.; STEINBRINK, J.; SEXTON, M.; LYON, G.; MEHTA, A.; PHADKE, V.; WOODWORTH, M. (2019). 2693. Clinical Presentation of Toxoplasmosis and 30-Day Mortality in Transplant Recipients at Two Academic Medical Centers. Open Forum Infectious Diseases, 6, S946 - S947. https://doi.org/10.1093/ofid/ofz360.2370
ADEKUNLE, R.; SHERMAN, A.; SPICER, J.; MESSINA, J.; STEINBRINK, J.; SEXTON, M.; LYON, G.; MEHTA, A.; PHADKE, V.; WOODWORTH, M. (2021). Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers. Transplant Infectious Disease, 23. https://doi.org/10.1111/tid.13636
AGÊNCIA FIOCRUZ DE NOTÍCIAS. Neglected Diseases. 2022. Available at: https://agencia.fiocruz.br/doencas-negligenciadas#:~:text=As%20doen%C3%A7as%20negligenciadas%20s%C3%A3o%20aquelas,medicamentos%20e%20em%20seu%20controle.
ANACLETO-SANTOS, J.; CALZADA, F.; LÓPEZ-CAMACHO, P.Y.; LÓPEZ-PÉREZ, T. DE J.; CARRASCO-RAMÍREZ, E.; CASARRUBIAS-TABAREZ, B.; FORTOUL, T.I.; ROJAS-LEMUS, M.; LÓPEZ-VALDÉS, N.; RIVERA-FERNÁNDEZ, N. Evaluation of the anti-Toxoplasma gondii efficacy, cytotoxicity, and GC/MS profile of Pleopeltis crassinervata active subfractions. Antibiotics, 12 (5) (2023), p. 889, DOI: 10.3390/antibiotics12050889.
ANNAN, K.; SARPONG, K.; ASARE, C.; DICKSON, R.; K.I. AMPONSAH, K.I.; GYAN, B.; OFORI, M.; GBEDEMA, S.Y. In vitro anti-plasmodial activity of three herbal remedies for malaria in Ghana : Adenia cissampeloides (Planch.) Harms., Termina liaivorensis A. Chev, and Elaeis guineensis Jacq. Pharmacogn. Res., 4 (4) (2012), pp. 225-229, 10.4103/0974-8490.102270
ANVARI, D., SHARIF, M., SARVI, S., AGHAYAN, S., GHOLAMI, S., PAGHEH, A., HOSSEINI, S., SABERI, R., NAYERI, T., HOSSEININEJAD, Z.; DARYANI, A. (2019). Seroprevalence of Toxoplasma gondii infection in cancer patients: A systematic review and meta-analysis. Microbial pathogenesis, 129, 30-42. https://doi.org/10.1016/j.micpath.2019.01.040
ATTIAS, M.; TEIXEIRA, D.E.; BENCHIMOL, M.; VOMMARO, R.C.; CREPALDI, P.H.; DE SOUZA, W. The life-cycle of Toxoplasma gondii reviewed using animations. Parasites & Vectors. V. 13, Article number: 588 (2020) Link at : https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-020-04445-z?utm_source=chatgpt.com
BENOIT-VICAL, F.; SANTILLANA-HAYAT, M.; KONE-BAMBA, D.; MALLIE, M.; DEROUIN, F. Anti- Toxoplasma activity of vegetal extracts used in West African traditional medicine. Parasite, 7 (1) (2000), pp. 3-7, 10.1051/parasite/2000071003
BENTES LOPES, J., GASPAR, S. A., GOMES, N. B. DE N., IABRUDI, R. C., CRUZ FILHO, F. C., GAYER, D. DE S., EZEQUIEL, T. D. G., BOLOGNANI, F. DE A., MALFACINI, S. DA S., GORINI, C. C., DE FREITAS, J. V. M., VIEIRA, I. F., KUSTER, R. M., LAGE, C. L. S., DA SILVA, S., BRIOSO, P. S. T., ALEXANDRE DOS SANTOS PYRRHO, A. DOS S.; VARRICCHIO, M. C. B. N. (2024). Environmental potential of plant use: Resource management in the face of climate uncertainty. Latin American Economy Observatory, 22(4), 1–33. https://doi.org/10.55905/oelv22n4-019.
BISHT, B.S.; BANKOTI, H.; BHARTI, T. A review on therapeutic uses of terpenoids. J. Drug Deliv. Therapeut., 11 (2021), pp. 182-185, 10.22270/jddt.v11i1-s.4523
BLUME, M.; SEEBER, F. (2018). Metabolic interactions between Toxoplasma gondii and its host. F1000Research, 7. https://doi.org/10.12688/f1000research.16021.1
BURKILL, H.M. The Useful Plants of West Africa. (second ed.), Royal Botanic Garden (1985), pp. 458-459.
BURKILL, H.M. The Useful Plants of West Tropical Africa. (second ed.), vol. 3, Royal Botanic Gardens, Kew-London (1997). Families J–L
CAZUMBÁ, A. DA S.; CÉZAR DA SILVA, G.V.; REBELO, R. DE M.; HAMMES, R. S. S.; GASPAR, S.A.; GOMES, N. B. DE N.; VARRICCHIO, M. C. B. N.; DA SILVA, S.; CASTELO BRANCO, M. T. L.; PYRRHO, A. DOS S. (2025) NEGLECTED DISEASES: Leishmaniasis and Natural Products (Actualization Review). INFO_SAPB. Revista de suporte ao Projeto Saúde Ambiental, Parasitologia, Bioética do Laboratório de Imunoparasitologia e Análises Toxicológicas (Projeto SAPB-LIPAT) da Faculdade de Farmácia da UFRJ. V9 - n2 - Out 2025. Available at: https://sites.google.com/view/lipat/sapb-revista_info-sapb?authuser=0#h.oceiqv3p0z55.
CDC. CENTER FOR DISEASES CONTROL. About Toxoplasmosis (prevention and hygien). 2024. Link at: https://www.cdc.gov/toxoplasmosis/about/index.html?utm_source=chatgpt.com
CDC. CENTER FOR DISEASES CONTROL. Toxoplasmosis: An Important Message for Cat Owners (PDF). 2024a. Link at: https://www.cdc.gov/parasites/toxoplasmosis/resources/printresources/catowners.pdf?utm_source=chatgpt.com
CDC. CENTER FOR DISEASES CONTROL. Clinical Care of Toxoplasmosis. 2024b. Link at:https://www.cdc.gov/toxoplasmosis/hcp/clinical-care/index.html?utm_source=chatgpt.com
CHEN, Q-W.; DONG, K.; QIN, H-X.; YANG, Y-K.; HE, J-L.; LI, J.; ZHENG, Z-W.; CHEN, D-L.; CHEN, J-P. Direct and Indirect Inhibition Effects of Resveratrol against Toxoplasma gondii Tachyzoites In Vitro. Antimicrobial Agents and Chemotherapy. Washington, Feb 26; 63(3): e01233-18. 2019. DOI: 10.1128/AAC.01233-18. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6395936/. Access in: Apr, 8. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC6395936/
CHEN, J., LIAO, W.; PENG, H. (2022). Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.959300
CHEN, M.; YANG, P.; XIN, Z.; CHEN, J.; ZOU, W.; ZHOU, L.; YANG, L.; PENG, J.; PENG, H. (2023). Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1173379
CHOI, J.-W.; LEE, J.; LEE, J.-H.; PARK, B.-J.; LEE, E.J.; SHIN, S.; CHA, G.-H.; LEE, Y.-H.; LIM, K.; YUK, J.-M. Omega-3 polyunsaturated fatty acids prevent Toxoplasma gondii infection by inducing autophagy via AMPK activation. Nutrients, 11 (2019), p. 2137, 10.3390/nu11092137
CONG, W.; LIU, G.; MENG, Q.; DONG, W.; QIN, S.; ZHANG, F.; ZHANG, X.; WANG, X.; QIAN, A.; ZHU, X. (2015). Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer letters, 359 2, 307-13. https://doi.org/10.1016/j.canlet.2015.01.036
CONSENSUS AI. AI-powered search engine for research at https://consensus.app
COUTINHO, B.; ROMAGNOLI, L.; FERNANDES, AC; RIBEIRO, CMM; LEIRA, MF; BOLOGNANI, F. DE A.; GIORGI, J. DOS SJ; VARRICCHIO, MCBN. Pharmaceutical preparations from Echinacea: immunomodulatory potential in cancer. Brazilian Journal of Development, v.12, n.2, 2026. ISSN 2525-8761. DOI: https://doi.org/10.34117/bjdv12n2-088. Available at: https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/issue/view/316.
DE CARVALHO, C.C.C.R.; CARAMUJO, M.J. The various roles of fatty acids.
Molecules, 23 (2018), p. 2583, 10.3390/molecules23102583
DE SOUZA, G.; SILVA, R.J.; MILIÁN, I.C.B.; ROSINI, A.M.; DE ARAÚJO, T.E.; TEIXEIRA, S.C.; OLIVEIRA, M.C.; FRANCO, P.S.; DA SILVA, C.V.; MINEO, J.R. et al. Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants. Sci. Rep., 11 (2021), Article 12709, DOI: 10.1038/s41598-021-92120-3.
DUPONT, D.; ROBERT, M.; BRENIER-PINCHART, M.; LEFEVRE, A.; WALLON, M.; PELLOUX, H. (2023). Toxoplasma gondii, a plea for a thorough investigation of its oncogenic potential. Heliyon, 9. https://doi.org/10.1016/j.heliyon.2023.e22147
EBONG, P.E.; OWU, D.U.; ISONG, E.U. Influence of palm oil (Elaesis guineensis) on health. Plant Foods Hum. Nutr., 53 (3) (1999), pp. 209-222, 10.1023/A:1008089715153
ELKORAICHI, I.; MOIRÉ, N.; RAIS, S.; DIMIER-POISSON, I. ;DAOUDI, F., DEBIERRE-GROCKIEGO, F. Extracts of food and medicinal plants sold in Moroccan markets induce apoptosis-like in Toxoplasma gondii tachyzoites in vitro. Scientific African. V. 27, March 2025, e02529.
ENDO, M.; SHIGETOMI, K.; MITSUHASHI, S.; IGARASHI, M.; UBUKATA, M.
Isolation, structure determination and structure–activity relationship of anti-toxoplasma triterpenoids from Quercus crispula Blume outer bark. J. Wood Sci., 65 (1) (2019), p. 3, 10.1186/s10086-019-1782-8.
EZZATKHAH, F.; MAHMOUDVAND, H.; RAZIANI, Y. The role of Curcuma longa essential oil in controlling acute toxoplasmosis by improving the immune system and reducing inflammation and oxidative stress. Front. Cell. Infect. Microbiol., Sec. Parasite and Host. 26 April 2023. V.13. DOI: https://doi.org/10.3389/fcimb.2023.1161133
FERNÁNDEZ-SABÉ, N., CERVERA, C., FARIÑAS, M., BODRO, M., MUÑOZ, P., GURGUÍ, M., TORRE-CISNEROS, J., MARTÍN-DÁVILA,P., NOBLEJAS, A., LEN, Ò., GARCIA-REYNE, A., DEL POZO, J.; CARRATALÁ, J. (2012). Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 3, 355-61.https://doi.org/10.1093/cid/cir806
https://academic.oup.com/cid/article-abstract/54/3/355/303016?redirectedFrom=fulltext
FILLOY, A.; GARCIA-GARCIA, O.; FERNÁNDEZ-LORENTE, L. (2013). Chorioretinitis as the First Sign of Acquired Toxoplasmosis Transmitted from Donor following Kidney Transplantation: Case Report and Review of the Literature. Ocular Immunology and Inflammation, 21, 34 - 35. https://doi.org/10.3109/09273948.2012.726390
FRANCÍ, E.; ADEKUNLE, R.; NUCCI, M.; POUCH, S. (2023). Complex considerations – Fever and pancytopenia after solid organ transplantation. Transplant Infectious Disease, 25. https://doi.org/10.1111/tid.14079
GAY, J.; GENDRON, N.; VERNEY, C.; JOSTE, V.; DARDÉ, M.; LOHÉAC, C.; VRTOVSNIK, F.; ARGY, N.; HOUZÉ, S. (2019). Disseminated toxoplasmosis associated with hemophagocytic syndrome after kidney transplantation: A case reportand review. Transplant Infectious Disease, 21. https://doi.org/10.1111/tid.13154
GAYER, D. Preventive measures against Toxoplasmosis. Booklet, 2025. Link available at: https://sites.google.com/view/lipat/sapb-artigos?authuser=0#h.5k94zyaj8avd. Access in 2026, January 13.
GIORGI, J. DOS S.J.; COUTINHO, B.; LEIRA, M.F.; BOLOGNANI, F. DE A.; GIORGI, M.S.; PYRRHO, A. DOS S.; CASTELO BRANCO, MTL.; VARRICCHIO, MCBN. Euphorbium (Euphorbia resinifera): a revision study. PROJEÇÃO E DOCÊNCIA, v.17, n.1, de 2026. Curitiba. ISSN 2178-6275. DOI: https://doi.org/10.54899.rpd.v17n1-2561. Available at: https://projecaociencia.com.br/index.php/Projecao3/issue/view/190.
GOMES, N. B. DE N.; IABRUDI, R.C.; MACEDO REBELO, R. DE; GASPAR, S. A.; VARRICCHIO, M. C. B. N.; BRIOSO, P. S. T.; DA SILVA, S.; PYRRHO, A. DOS S. Leishmaniose, produtos naturais, bioeconomia e desenvolvimento sustentável. Brazilian Journal of Development. 2023. Disponível em: - https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/article/view/62510/44980
GOMES, N. B. DE N.; FREIRE SOUZA SILVA, F.; WASIM, N.; IABRUDI, R.C.; DA SILVA, S.; BRIOSO, P. S. T.; VARRICCHIO, M.C.B.N.; PYRRHO, A. DOS S.
Esquistossomose e o potencial bioeconômico brasileiro. Brazilian Journal of Development. Curitiba, v.9, n.10, p. 28700-28711, oct., 2023a. Disponível em:
https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/issue/view/220.
HANSEL-MARTINS, C.; VARRICCHIO, M.C.B.N.; PYRRHO,A. DOS S.; DA SILVA, J.; SILVA,E.P.; DA SILVA, S.; CASTELO BRANCO, M.T.L. Post-COVID-19 syndrome: neurobehavioral disorders and the potential of functional foods for symptom relief. Caderno Pedagógico, 2025, v.22, n.13. ISSN 1983-0882. DOI: https://doi.org/10.54033/cadpedv22n13-036. Link at: https://ojs.studiespublicacoes.com.br/ojs/index.php/cadped/issue/view/163
HÉBRAUD, B., KAMAR, N., BORDE, J., BESSIÈRES, M., GALINIER, M. ; ROSTAING, L. (2008). Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure. NDT Plus, 1,429 - 432. Link at: https://doi.org/10.1093/ndtplus/sfn1593
HMIDOUCHE, O.; BOUFTINI, K.; CHAFIK, A.; KHOURI, S.; RCHID, H.; RAHIMI, A.; MIMOUNI, M.; MAAROUF, E.; ZAAKOUR, F.; NMILA, R.; KHOUCHLAA, A. Ethnomedicinal Use, Phytochemistry, Pharmacology, and Toxicology of Euphorbia resinifera O. Berg. (B): A Review. J. Zool. Bot. Gard. 2023, 4, 364–395. https://doi.org/10.3390/jzbg4020029.
HODGE, J., COGHILL, A., KIM, Y., BENDER, N., SMITH-WARNER, S., GAPSTUR, S., TERAS, L., GRIMSRUD, T., WATERBOER, T.; EGAN, K. (2021). Toxoplasma gondii infection and the risk of adult glioma in two prospective studies. International Journal of Cancer, 148, 2449 - 2456. https://doi.org/10.1002/ijc.33443
HUANG, M.; CAO, X.; JIANG, Y.; SHI, Y.; MA, Y.; HU, D.; SONG, X. Evaluation of the Combined Effect of Artemisinin and Ferroptosis Inducer RSL3 against Toxoplasma gondii. Int J Mol Sci. 2022, Dec 23; 24(1): 229. DOI: 10.3390/ijms24010229.
KA, F.; SALIBINDLA, D.; KENDLER, A. (2024). Disseminated Toxoplasma Gondii Infection in a Deceased Donor Kidney Transplant Recipient: A Fatal Case Report. American Journal of Clinical Pathology.162. DOI: https://doi.org/10.1093/ajcp/aqae129.007
KALANI, H.; SHAKIB, P.; FARIDNIA, R.; HO, J.; MARDANSHAH, O.; DOLATSHAH, M.; SEPAHVAND, A.; CHERAGHIPOUR, K.; ZIVDARIA, M. Anti- Toxoplasma gondii Activity of Curcumin: A Systematic Review of Pre-clinical Studies. Infect Disord Drug Targets. 2023; 23(2): e200822207821. DOI: 10.2174/1871526522666220820185637.
KALANTARI, N., GORGANI-FIROUZJAEE, T., HASSANI, S., CHEHRAZI, M.; GHAFFARI, S. (2020). Association between Toxoplasma gondii exposure and hematological malignancies: A systematic review and meta-analysis. Microbial pathogenesis, 104440. https://doi.org/10.1016/j.micpath.2020.104440
KHAN, T.A.; AL NASR, I.S.; MUJAWAH, A.H.; KOKO, W.S. Assessment of Euphorbia retusa and Pulicaria undulata activity against Leishmania major and Toxoplasma gondii. Tropical Biomedicine 38(1): 135-141 (2021) https://doi.org/10.47665/tb.38.1.023.
LIU, Q., WANG, Z., HUANG, S., ZHU, X. (2015). Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasites & Vectors, 8. https://doi.org/10.1186/s13071-015-0902-6
LIU, L.; WANG, P.; XU, J.; XIA, C. (2019). Increased risk of Toxoplasma gondii infection in cancer patients: A meta-analysis of current evidence based on case-control study. Acta tropica, 192, 30-40. https://doi.org/10.1016/j.actatropica.2019.01.010
MAO, E.Y.; PAGE, S.W.; SLEEBS, B.E.; GANCHEVA, M.R.; WILSON, D.W. A review of natural products as a source of next-generation drugs against apicomplexan parasites. npj Antimicrobials and Resistance, London, v. 3, n. 1, art. 51, 2025. DOI: 10.1038/s44259-025-00119-x. Disponível em: https://www.nature.com/articles/s44259-025-00119-x. Acesso em: 8 abr. 2026. https://www.nature.com/articles/s44259-025-00119-x
MARQUES-SANTOS, L. et al. The search for drugs derived from natural products for Toxoplasma gondii infection treatment in the last 20 years: a systematic review. Current Topics in Medicinal Chemistry, Sharjah, v. 24, n. 22, p. 1960-2000, 2024. DOI: 10.2174/0115680266294509240617064335. Available at: https://www.researchgate.net/publication/381914641_The_Search_for_Drugs_Derived_from_Natural_Products_for_Toxoplasma_gondii_Infection_Treatment_in_the_Last_20_Years_-_A_Systematic_Review. Accessed in: 2026, Apr 8.
MARTINA, M., CERVERA, C., ESFORZADO, N., LINARES, L., TORREGROSA, V., SANCLEMENTE, G., HOYO, I., COFÁN, F., OPPENHEIMER, F., MIRÓ, J., CAMPISTOL, J.; MORENO, A. (2011). Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review. Transplant International, 24. DOI: https://doi.org/10.1111/j.1432-2277.2010.01173.x
https://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2010.01173.x
MORADI, F.; DASHTI, N.; BAHADORAM, F.; NOURI, F. B.; FATEMI, A.; ZAHMATKESH, M. Curcumin ameliorates chronic Toxoplasma gondii infection-induced affective disorders through modulation of proinflammatory cytokines and oxidative stress. Iranian Journal of Basic Medical Sciences, Mashhad, v. 26, n. 4, p. 428-437, 2023. DOI: 10.22038/IJBMS.2023.68487.14937. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC10008396/. Acesso em: 8 abr. 2026. https://pubmed.ncbi.nlm.nih.gov/37009013/
NAGAMUNE, K.; BEATTY, W.L.; SIBLEY, L.D. Artemisinin Induces Calcium-Dependent Protein Secretion in the Protozoan Parasite Toxoplasma gondii. ASM Journals/Eukaryotic Cell. 2007. Vol. 6, No. 11. DOI: https://doi.org/10.1128/ec.00262-07
OUATTARA, N.; ISSOUFOU-TINY, M.; MAGID, A.A.; ESCOTTE-BINET, S.; YAO-KOUASSI, P.A.; VILLENA, I.; VOUTQUENNE-NAZABADIOKO, L. Anti-Toxoplasma gondii screening of eight species used in Côte d’Ivoire, and bio-guided isolation of three previously undescribed nor-sesquiterpenoids and one benzyl glycoside from Elaeis guineensis leaves. Phytochemistry. V. 234, June 2025, 114442. https://www.sciencedirect.com/science/article/pii/S0031942225000652
PALHARINI, JG; RICHTER, AC; SILVA, MF; FERREIRA, FB; PIROVANI, CP; NAVES, KSC; GOULART, VA; MINEO, TWP; SILVA, MJB; SANTIAGO, FM. Eutirucallin: A Lectin with Antitumor and Antimicrobial Properties. Frontiers in Cellular and Infection Microbiology. 2017 Apr 25;7:136. doi: 10.3389/fcimb.2017.00136 https://doi.org/10.3389/fcimb.2017.00136
PASTRE, M.J. Jejunal response to Toxoplasma gondii infection in rats with different strains: an exploratory study of the serotonergic response to acute infection and the effects of immunostimulation by Echinacea purpurea in chronic infection. 2022. 139 p. Thesis (Doctorate in Biosciences and Physiopathology) - State University of Maringá, 2022, Maringá, PR.
REBELO, R. DE M.; HAMMES, R. S. S.; CAVALCANTI, L. C.; GAYER, D. S.; VARRICCHIO, M.T.; VARRICCHIO, M.C.B.N.; DA SILVA, J.; PYRRHO, A. DOS S.; LAGE, C.L.S.; CASTELO BRANCO, M.T.L. Environmental Pollution, Smoking and Public Health: Environmental Technology Resources. Individual chapter in Sustainability and environmental management [e-book/livro eletrônico] Organização Dariane Cristina Catapan. -- 1. ed. -- Curitiba, PR: Editora Foco, 2025. ISBN: 978-65-83117-16-8. DOI: 10.54033/stebook.978-65-83117-16-8_4.
RENOULT, É., GEORGES, E., BIAVA, M., HULIN, C., FRIMAT, L., HESTIN, D.; KESSLER, M. (1997). Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clinical infectious diseases: an official publication of theInfectious Diseases Society of America, 2 4 4, 625-34. https://doi.org/10.1093/clind/24.4.625
ROBERT-GANGNEUX, F. et al. Toxoplasmosis in transplant recipients, Europe, 2010–2014. Emerging Infectious Diseases, Atlanta, v. 24, n. 8, p. 1497-1504, 2018. DOI: 10.3201/eid2408.180045. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30014843/.
SANCHEZ, S.; BESTEIRO, S. (2021). The pathogenicity and virulence of Toxoplasma gondii. Virulence, 12, 3095 - 3114. https://doi.org/10.1080/21505594.2021.2012346
SAPB-LIPAT PROJECT, Pharmacy Faculty of Federal University of Rio de Janeiro: Toxoplasmosis, Refugées, Spiritual and Environmental Health Event, 2018. Available at: https://sites.google.com/view/lipat/sapb-eventos_sapb?authuser=0#h.67d9h2wossw0. Acess in: 2026, January, 13.
SEPULVEDA-ARIAS, J.C.; VELOZA, L.A.; MANTILLA-MURIEL, L.E. Anti-Toxoplasma activity of natural products: a review. Recent Pat Anti infect Drug Discov. 2015; 9(3):186-94. DOI: 10.2174/1574891x10666150410120321.
SHIHAB, R., SULAIMAN, E.; ABDEEN, A. (2025). The Relationship Between Toxoplasmosis and Prostate Cancer Patients. Indonesian Journal on Health Science and Medicine. https://doi.org/10.21070/ijhsm.v2i1.58
SONG, Y., YUAN, H., YANG, X., YANG, Z., REN, Z., QI, S., HE, H., ZHANG, X., JIANG, T., YUAN, Z. (2024). The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development. Parasites & Vectors, 17. https://doi.org/10.1186/s13071-024-06240-6
SOUNDARARAJAN, V.; SREENIVASAN, S. Antioxidant activity of Elaeis guineensis leaf extract: an alternative nutraceutical approach in impeding aging. APCBEE Procedia, 2 (2012), pp. 153-159, 10.1016/j.apcbee.2012.06.028.
TOW, W.K.; GOH, A.P.; SUNDRALINGAM, U.; PALANISAMY, U.D.; SIVASOTHY, Y. Flavonoid composition and pharmacological properties of Elaeis guineensis Jacq. leaf extracts: a systematic review. Pharmaceuticals, 24 (10) (2021), p. 961, 10.3390/ph1410096114
TEPONGNING, R.N.; MBAH, J.N.; AVOULOU, F.L.; JERME, M.M.; NDANGA, E.K.; FEKAM, F.B. Hydroethanolic extracts of Erigeron floribundus and Azadirachta indica reduced Plasmodium berghei parasitemia in BALB/c mice. Evid Based Complement Alternat Med, 21 (2018), Article 5156710, 10.1155/2018/5156710
US-FDA. U.S. FOOD AND DRUG ADMINISTRATION. Foodborne illness – Toxoplasmosis. Link at: https://www.fda.gov/food/people-risk-foodborne-illness/toxoplasma-prevention-you-become-pregnant-food-safety-moms-be?utm_source=chatgpt.com
VARRICCHIO, MCBN, NAGAMATSU, D.; BOLOGNANI, F. DE A.; GIORGI, MS.; BENTES LOPES, J.; PYRRHO, A DOS S.; DA SILVA, S.; CASTELO BRANCO, M.T.L.; DE FREITAS, F.J. Euphorbia tirucalli dynamized and cancerinic state: reflections and evidences after 25 years of studies. Caderno Pedagógico. v.22, n.12, 2025a. ISSN 1983-0882. DOI: https://doi.org/10.54033/cadpedv22n12-044. Available at: https://ojs.studiespublicacoes.com.br/ojs/index.php/cadped/issue/view/160.
WENDLING DA SILVA, AV; WASIM, N.; NAGAMATSU, D.; GASPAR, S.A.; VARRICCHIO, MCBN.; PYRRHO, A. DOS S.; DA SILVA, S. EUPHORBIA tirucalli, Acupuncture and Biotechnological Potential of Latex: Preliminary Qualitative Evaluation and Perspectives. Individual Chapter In Expanded Science: Innovation and Research. Pg. 555 – 573. ISBN: 978-65-6109-190-9. DOI: 10.56238/sevened2025.029-. 2025-07-01. Link at: https://sevenpubl.com.br/editora/issue/view/228
WORLD HEALTH ORGANIZATION. Toxoplasma gondii: background document for the WHO Guidelines for drinking-water quality and the WHO Guidelines on sanitation and health. Geneva: WHO, 2025. 17 p. Disponível em: https://iris.who.int/server/api/core/bitstreams/16951c0b-7865-4a79-890e-6e2da6206509/content. Acesso em: 31 mar. 2026.
XIAO, J.; YOLKEN, R. (2015). Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases. Acta Physiologica, 213. https://doi.org/10.1111/apha.12458
YANG, X., SONG, Y., YUAN, H., MAHMMOD, Y., YANG, Z., TAN, J., LIU, R., YANG, J., ZHANG, X., YUAN, Z. (2022). Mechanism of Interaction Between Acute and Chronic Toxoplasma gondii Infection and Lung Cancer. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4208338
YAO, N.; XU, Q.; HE, J-K.; PAN, M.; HOU, Z-F.; LIU, D-D.; TAO, J-P.; HUANG, S-Y. Evaluation of Origanum vulgare Essential Oil and Its Active Ingredients as Potential Drugs for the Treatment of Toxoplasmosis. Front. Cell. Infect. Microbiol. Sec. Clinical and Diagnostic Microbiology and Immunology. 2021, November, 21. V. 11. Link at: https://doi.org/10.3389/fcimb.2021.793089
